公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2009 | Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan | Lin C.-Y.; Chen M.-Y.; SZU-MIN HSIEH ; WANG-HUEI SHENG ; HSIN-YUN SUN ; Lo Y.-C.; CHIEN-CHING HUNG ; SHAN-CHWEN CHANG | Journal of Microbiology, Immunology and Infection | 2 | 2 | |
2012 | Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma | Chang V.H.S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO ; Shan Y.-S.; Hsu C.-F.; Lin C.-Y.; Tsai K.K.C.; Yu W.C.Y.; Ch'Ang H.-J. | American Journal of Pathology | 34 | 30 | |
2008 | Label-free imaging of Drosophila larva by multiphoton autofluorescence and second harmonic generation microscopy | Lin C.-Y.; Hovhannisyan V.; Wu J.-T.; Lin C.-W.; Chen J.-H.; SUNG-JAN LIN ; Dong C.-Y. | Journal of Biomedical Optics | 20 | 18 | |
2022 | Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan | Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO ; Yu M.-L.; TACR investigators | Journal of the Formosan Medical Association | 3 | 0 | |
2022 | Lidocaine and Bupivacaine Downregulate MYB and DANCR lncRNA by Upregulating miR-187-5p in MCF-7 Cells | Lin C.-Y.; Tseng W.-T.; Chang Y.-Y.; MONG-HSUN TSAI ; ERIC YAO-YU CHUANG ; TZU-PIN LU ; LIANG-CHUAN LAI | Frontiers in Medicine | 3 | 2 | |
2007 | Linkage of Graves' disease to the human leucocyte antigen region in the Chinese-Han population in Taiwan | PEI-LUNG CHEN ; Fann C.S.-J.; Chang C.-C.; Wu I.-L.; WEI-YIH CHIU ; Lin C.-Y.; WEI-SHIUNG YANG ; TIEN-CHUN CHANG | Clinical Endocrinology | 8 | 9 | |
2009 | Lipoprotein lipase variants associated with an endophenotype of hypertension: Hypertension combined with elevated triglycerides | PEI-JER CHEN ; Jou Y.-S.; Fann C.S.J.; Chen J.-W.; Chung C.-M.; Lin C.-Y.; Wu S.-Y.; Kang M.-J.; Chen Y.-C.; Jong Y.-S.; Lo H.-M.; Kang C.-S.; Chen C.-C.; Chang H.-C.; Huang N.-K.; Wu Y.-L.; Pan W.-H. | Human Mutation | 12 | 10 | |
2016 | Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lai M.-W.; Wu T.-C.; Wu S.-F.; Lee C.-M.; Yang S.-S.; Chu H.-C.; Wang T.-E.; Chen B.-W.; Chuang W.-L.; Soon M.-S.; Lin C.-Y.; Chiou S.-T.; Kuo H.-S.; DING-SHINN CHEN ; Yang Y.-J.; Lo G.-H.; Kong M.-S.; Wang P.-M.; Yang C.-C.; Chu C.-H.; Lin L.-H.; Chien R.-N.; Lee T.-H.; Yang K.-C.; Liao L.-Y.; Mo L.-R.; Liu J.-D.; Yang T.-H.; Lo C.-C.; Tsai M.-H.; Chou C.-H.; Cheng Y.-S. | Gastroenterology | 174 | 150 | |
2021 | Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) | Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO ; CHEN-HUA LIU ; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU ; Yu M.-L. | Hepatology International | 4 | 5 | |
2021 | Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan | Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators | Journal of Gastroenterology and Hepatology (Australia) | 2 | 3 | |
2014 | Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients | Lin H.-H.; Liou H.-H.; MING-SHIOU WU ; Lin C.-Y.; Huang C.-C. | Nephrology | 34 | 31 | |
2012 | Low prevalence of major depressive disorder in Taiwanese adults: Possible explanations and implications | Shih-Cheng Liao ; WEI J. CHEN ; MING-BEEN LEE ; Lung F.-W.; Lai T.-J.; Liu C.-Y.; Lin C.-Y.; Yang M.-J.; Chen C.-C. | Psychological Medicine | 100 | 98 | |
2014 | Maintenance of human adipose derived stem cell (hASC) differentiation capabilities using a 3D culture | Lin C.-Y.; Huang C.-H.; Wu Y.-K.; NAI-CHEN CHENG ; Yu J. | Biotechnology Letters | 13 | 10 | |
2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Wang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | Journal of the Formosan Medical Association = Taiwan yi zhi | 90 | 87 | |
2013 | A mathematical model for water network synthesis involving mixed batch and continuous units | Lee J.-Y.; Chen C.-L. ; Lin C.-Y. | Industrial and Engineering Chemistry Research | 9 | 7 | |
2006 | Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells | Kiyomiya K.-I.; MING-SHYUE LEE ; Tseng I.-C.; Zuo H.; Barndt R.J.; Johnson M.D.; Dickson R.B.; Lin C.-Y. | American Journal of Physiology - Cell Physiology | 53 | 51 | |
2011 | Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells | Chou F.-P.; Xu H.; MING-SHYUE LEE ; Chen Y.-W.; Richards O.X.D.; Swanson R.; Olson S.T.; Johnson M.D.; Lin C.-Y. | American Journal of Physiology - Cell Physiology | 7 | 7 | |
2010 | Matriptase is involved in ErbB-2-induced prostate cancer cell invasion | Wu S.-R.; Cheng T.-S.; Chen W.-C.; Shyu H.-Y.; Chun-Jung Ko ; HSIANG-PO HUANG ; Teng C.-H.; Lin C.-H.; Johnson M.D.; Lin C.-Y.; MING-SHYUE LEE | American Journal of Pathology | 34 | 31 | |
2017 | Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity | Tseng C.-C.; Jia B.; Barndt R.; Gu Y.; Chen C.-Y.; Tseng I.-C.; SHENG-FANG SU ; Wang J.-K.; Johnson M.D.; Lin C.-Y. | PLoS ONE | 27 | 26 | |
1989 | Membranous nephropathy in 52 hepatitis B surface antigen (HGsAg) carrier children in Taiwan | Hsu H.-C.; CHIA-YI WU ; Lin C.-Y.; Lin G.-J.; Chen C.-H.; Huang F.-Y. | Kidney International | 55 | 33 | |